Stock listing
Roivant Sciences Ltd.
Selected listing: ROIV · BX · CHF · CH
Roivant Sciences Ltd. (BX Swiss: ROIV), Health Technology. Latest release Sep 23, 2026: Roivant Announces Topline Results from Proof-of-Concept Study…
- Ticker
- BX Swiss: ROIV
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BX Swiss
- Currency
- CHF
About Roivant Sciences Ltd.
Roivant Sciences Ltd. is a public company traded under the ticker ROIV in the American market. Roivant focuses on advancing innovative therapies and technologies to improve patient outcomes.
Latest news from Roivant Sciences Ltd.
Roivant Announces Topline Results from Proof-of-Concept Study of IMVT-1402 in Cutaneous Lupus Erythematosus
September 23, 2026
Roivant Announces Positive Results from PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) and Unveils Ongoing Phase 3 PHrontier Study
September 8, 2026
Roivant to Present Topline Results from the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) at the ERS Congress 2026 on Tuesday, September 8, 2026, and Host Investor Call
September 6, 2026
Pulmovant to Present Topline Results from the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) at the ERS Congress 2026 on Tuesday, September 8, 2026
September 6, 2026
Roivant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S.
August 27, 2026
Roivant Sciences Ltd. earnings calls
Roivant Sciences Ltd. (ROIV) Q1 2026 Earnings Call
August 6, 2026 · Replay with transcript and chapters
Roivant Sciences Ltd. (ROIV) Q4 2025 Earnings Call
May 20, 2026 · Replay with transcript and chapters
Roivant Sciences Ltd. (ROIV) Q3 2025 Earnings Call
February 6, 2026 · Replay with transcript and chapters
Roivant Sciences Ltd. (ROIV) Q2 2025 Earnings Call
November 10, 2025 · Replay with transcript and chapters
Roivant Sciences Ltd. (ROIV) Q1 2025 Earnings Call
August 11, 2025 · Replay with transcript and chapters
Roivant Sciences Ltd. (ROIV) Q4 2024 Earnings Call
May 29, 2025 · Replay with transcript and chapters
Research Roivant Sciences Ltd.
Roivant Sciences Ltd. company profile
View the public company page for Roivant Sciences Ltd. on 6ix.
Roivant Sciences Ltd. news
Read company news and market updates connected to Roivant Sciences Ltd..
Roivant Sciences Ltd. investor events
Find investor webinars, events, and replay context for Roivant Sciences Ltd..
Alternate listings
ROIV:NASDAQ
US · USD
Alternate listing for Roivant Sciences Ltd.; the primary context on this page is ROIV:BX.
87S:GETTEX
DE · EUR
Alternate listing for Roivant Sciences Ltd.; the primary context on this page is ROIV:BX.
A3C4MS:LSX
DE · EUR
Alternate listing for Roivant Sciences Ltd.; the primary context on this page is ROIV:BX.
87S:TRADEGATE
DE · EUR
Alternate listing for Roivant Sciences Ltd.; the primary context on this page is ROIV:BX.
A3C4MS:LS
DE · EUR
Alternate listing for Roivant Sciences Ltd.; the primary context on this page is ROIV:BX.
ROIV:BOATS
US · USD
Alternate listing for Roivant Sciences Ltd.; the primary context on this page is ROIV:BX.
87S:DUS
DE · EUR
Alternate listing for Roivant Sciences Ltd.; the primary context on this page is ROIV:BX.
87S:FWB
DE · EUR
Alternate listing for Roivant Sciences Ltd.; the primary context on this page is ROIV:BX.
87S:MUN
DE · EUR
Alternate listing for Roivant Sciences Ltd.; the primary context on this page is ROIV:BX.
87S:SWB
DE · EUR
Alternate listing for Roivant Sciences Ltd.; the primary context on this page is ROIV:BX.